HB-1614
Asset
Inhibits hyaluronan synthesis to reduce inflammatory, fibrotic, and metabolic signaling.
- Stage
- Stage not known
- Modality
- Small molecule
- Target
- Not known
- 0
- Indications
- 0
- Trials
- 1
- Developer
Indications
0In the full profile
- Owner and partners1
Every asset’s record: target, stage, trials and the evidence behind it.